|
Volumn 21, Issue SUPPL. 4, 2006, Pages 23-26
|
Use of mannanoligosacharides as an adjuvant treatment for gastrointestinal diseases and this effects on E. coli inactivated in dogs
a b a a b |
Author keywords
Dog diseases; Escherichia coli; Gastroenteritis; Probiotics
|
Indexed keywords
CYANOCOBALAMIN;
ENROFLOXACIN;
MANNAN;
MANNAN OLIGOSACCHARIDE;
MEBENDAZOLE;
METOCLOPRAMIDE;
OLIGOSACCHARIDE;
PRAZIQUANTEL;
PYRANTEL EMBONATE;
THIAMINE;
UNCLASSIFIED DRUG;
ADJUVANT THERAPY;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTHELMINTIC ACTIVITY;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC THERAPY;
ARTICLE;
BLOOD CULTURE;
CONTROLLED STUDY;
DOG;
DRUG EFFECT;
ENTEROPATHOGENIC ESCHERICHIA COLI;
EVALUATION;
FECES CULTURE;
FECES MICROFLORA;
GASTROENTERITIS;
LEUKOCYTE;
LYMPHOCYTE;
NEUTROPHIL;
NONHUMAN;
PATHOGENIC ESCHERICHIA COLI;
TREATMENT OUTCOME;
ADJUVANTS, PHARMACEUTIC;
ANIMALS;
DIETARY SUPPLEMENTS;
DOG DISEASES;
DOGS;
ESCHERICHIA COLI;
ESCHERICHIA COLI INFECTIONS;
FECES;
GASTROENTERITIS;
LEUKOCYTE COUNT;
LYMPHOCYTES;
MANNANS;
NEUTROPHILS;
OLIGOSACCHARIDES;
|
EID: 33846908706
PISSN: 01028650
EISSN: 16782674
Source Type: Journal
DOI: 10.1590/S0102-86502006001000006 Document Type: Article |
Times cited : (14)
|
References (8)
|